Thompson Siegel & Walmsley’s Kindred Biosciences, Inc. KIN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-23,162	Closed	-$214K	–	726
2014 Q3	$214K	Buy	23,162 +8,262	+55%	+$112K	﹤0.01%	374
2014 Q2	$278K	Buy	14,900 +5,400	+57%	+$91.7K	0.01%	361
2014 Q1	$176K	Buy	+9,500	New	+$181K	﹤0.01%	390

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gruss Capital Management New York $422M AUM 9.91% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return